Uganda Seeks Shs 600 Billion for Vaccine City, President Pledges Support

The National Agricultural Research Organisation's (NARO) ambitious proposal to establish a Shs 600 billion vaccine and pharmaceutical city marks a significant step towards bolstering Uganda's self-sufficiency in critical health sectors. This initiative, championed by NARO's Governing Council Chairperson Dr. William Olaho Mukani, directly addresses the nation's vulnerability to imported medicines and aims to transform Uganda into a regional leader in vaccine production.

President Museveni's swift and positive response to the funding request underscores the government's commitment to advancing scientific innovation and agricultural productivity. By pledging support, the President signals a strategic investment in the country's future, recognizing that strengthening livestock health systems is paramount for economic growth and food security.

“

We are requesting government to provide Shs 600 billion over a period of three years to enable us to actualize this dream of establishing a vaccines and pharmaceutical city.

NARO's current success with the anti-tick vaccine, NAROVAC, demonstrates its capacity to scale up production and meet growing demand. The proposed city, housing multiple production plants, promises to significantly enhance this capability, not only for veterinary vaccines but potentially for human pharmaceuticals as well.

This project holds particular significance for Uganda, moving beyond mere agricultural research to encompass advanced manufacturing and technological development. It represents a tangible effort to reduce import dependency, foster local expertise, and create high-value jobs, aligning with the nation's broader goals of industrialization and economic diversification. The successful realization of this 'vaccine city' could redefine Uganda's role in the global health landscape.

“

The money being requested is not a lot. We shall ensure that it is made available.